(Q79370791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Neoadjuvant chemotherapy for bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Peter C Black

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Gordon A Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

H Barton Grossman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Colin P Dinney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

531-542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17115230%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00345-006-0113-z

22 December 2019

exact match

0 references

cites work

Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a new standard of care?

1 reference

12 December 2020

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer

1 reference

12 December 2020

Neo-adjuvant chemotherapy for invasive bladder cancer

1 reference

12 December 2020

The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.

1 reference

12 December 2020

Neoadjuvant chemotherapy for bladder cancer

1 reference

12 December 2020

Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2

1 reference

12 December 2020

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin

1 reference

12 December 2020

Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy

1 reference

12 December 2020

Pelvic lymph node dissection can be curative in patients with node positive bladder cancer

1 reference

12 December 2020

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

1 reference

12 December 2020

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group

1 reference

12 December 2020

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

1 reference

12 December 2020

The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy

1 reference

12 December 2020

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

12 December 2020

Bladder carcinoma as a systemic disease

1 reference

12 December 2020

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer

1 reference

12 December 2020

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

1 reference

12 December 2020

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies

1 reference

12 December 2020

Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant

1 reference

12 December 2020

Interpreting disparate responses to cancer therapy: the role of human population genetics

1 reference

12 December 2020

Hydronephrosis as a prognostic indicator in bladder cancer patients

1 reference

12 December 2020

Systemic chemotherapy options for metastatic bladder cancer

1 reference

12 December 2020

A European Organization for Research and Treatment of Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-XM0 transitional cell cancer of the bladder: evaluation of clinical response

1 reference

12 December 2020

Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance

1 reference

12 December 2020

Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer

1 reference

12 December 2020

Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.

1 reference

12 December 2020

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

12 December 2020

Debulking nephrectomy in metastatic renal cancer

1 reference

12 December 2020

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

1 reference

12 December 2020

Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER Program

1 reference

12 December 2020

Pharmacogenomics: from bedside to clinical practice

1 reference

12 December 2020

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

12 December 2020

Neoadjuvant and adjuvant therapy for rectal cancer

1 reference

12 December 2020

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

12 December 2020

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population

1 reference

12 December 2020

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

1 reference

12 December 2020

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

12 December 2020

Differences between urologists in United States and Canada in approach to bladder cancer.

1 reference

12 December 2020

Surgical factors influence bladder cancer outcomes: a cooperative group report

1 reference

12 December 2020

UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan

1 reference

12 December 2020

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

1 reference

12 December 2020

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

12 December 2020

Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

1 reference

12 December 2020

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

1 reference

12 December 2020

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

12 December 2020

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours

1 reference

12 December 2020

Complications of radical cystectomy: impact of the timing of perioperative chemotherapy

1 reference

12 December 2020

Medical treatment of early breast cancer. IV: neoadjuvant treatment

1 reference

12 December 2020

Overview of bladder cancer trials in the Radiation Therapy Oncology Group

1 reference

12 December 2020

An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma

1 reference

12 December 2020

Cystectomy for bladder cancer: a contemporary series

1 reference

12 December 2020

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium

1 reference

12 December 2020

Perioperative chemotherapy for bladder cancer

1 reference

12 December 2020

Can patient selection for bladder preservation be based on response to chemotherapy?

1 reference

12 December 2020

Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists

1 reference

12 December 2020

Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment.

1 reference

12 December 2020

Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival

1 reference

12 December 2020

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

12 December 2020

Patterns of care for the treatment of bladder cancer

1 reference

12 December 2020

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

12 December 2020

p53 and treatment of bladder cancer

1 reference

12 December 2020

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

12 December 2020

Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases

1 reference

12 December 2020

The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group

1 reference

12 December 2020